International Cancer Conference Journal

ISSN:

Journal Home

Journal Guideline

International Cancer Conference Journal Unclaimed

Springer Japan Japan
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

This online-only journal publishes original case reports on all types of cancer. In particular, we welcome not only case reports of educational value in the diagnosis and treatment of cancers, but also reports on molecularly analyzed cancer cases, including gene mutations, gene fusions, gene expression, and changes in copy number, regardless of their known clinical significance. Assessing the molecular analysis of a tumor usually requires a “cancer conference” in which experts from various fields discuss it. Even if the authors and their respective “cancer conference” were unable to determine the clinical significance of molecular changes at the time of submission and publication, their data may provide evidence that will help the scientific community develop precision medicine solutions in the future. We welcome case reports with reviews of the literature on similar cases, as they are more useful and valuable to readers than are reports of rare cases. International Cancer Conference Journal is the official publication of the Japan Society of Clinical Oncology (JSCO).   Presents an online-only collection of original case reports on all types of cancerIn particular, welcomes molecularly analyzed cancer casesThe Official Publication of the Japan Society of Clinical Oncology (JSCO)

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Oncology (-)
Price

2590 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

International Cancer Conference Journal

-

SJR Impact factor

-

H Index

-

Total Docs (Last Year)

-

Total Docs (3 years)

-

Total Refs

-

Total Cites (3 years)

-

Citable Docs (3 years)

-

Cites/Doc (2 years)

-

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


FAQS